This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated KIF5B Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-KIF5B WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~109.7 kDa | |
| Observed band | ~110 kDa | |
| Gel | 10% (catalog A01934-2) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A01934-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human A549, human HepG2, human Caco-2 (catalog A01934-2) |
| Gel % | 10% (catalog A01934-2) |
| Load | 30 ug; reducing conditions (catalog A01934-2) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A01934-2) |
| Membrane | nitrocellulose membrane (catalog A01934-2) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A01934-2) |
| Primary antibody | A01934-2 · 1:1000 (catalog A01934-2) |
| Primary incubation | overnight at 4°C (catalog A01934-2) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A01934-2) |
| Secondary incubation | 1.5 hour at RT (catalog A01934-2) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A01934-2) |
| Detection | ECL (catalog A01934-2) |
KIF5B is predicted at 109.7 kDa and observed at ~110 kDa; the small numerical difference reflects rounding, with no demonstrated migration shift.
| Band at ~110 kDa | Matches the observed KIF5B band and its 109.7 kDa predicted mass |
| Higher band under incomplete denaturation | May reflect retained assembly containing two KIF5B heavy chains; identity needs confirmation |
| Weak band in a soluble fraction | KIF5B can associate with the cytoskeleton and the cytoplasmic side of membranes |
| Doublet near ~110 kDa | Could involve the annotated Ser933 phosphorylation, but a visible shift is not established |
| Predicted KIF5B mass | 109.7 kDa, consistent with the observed ~110 kDa band |
| N-acetylalanine at residue 2 | Adds a small modification; no visible migration effect is established |
| Phosphoserine at residue 933 | Adds a small modification; no visible migration effect is established |
| Omega-N-methylarginine at residue 956 | Adds a small modification; no visible migration effect is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Cytoskeletal or membrane-associated KIF5B may be poorly recovered | Check extraction of cytoskeletal and membrane-associated material and include a positive lysate control |
| Band higher than expected | Incomplete denaturation may retain a heavy-chain assembly | Check denaturation conditions and verify the band with KIF5B depletion |
| Band lower than expected | The supplied features do not establish a smaller KIF5B product | Verify specificity with KIF5B depletion and check sample integrity |
| Multiple bands | A second band is not explained by a supplied isoform; Ser933 phosphorylation has no established visible shift | Compare bands after KIF5B depletion and assess phosphorylation only if a shift is reproducible |
| Weak or no signal | Recovery of cytoskeletal or membrane-associated KIF5B may be low | Check extraction and loading with a positive whole-cell lysate control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | glial cells | High | Protein (IHC) | HPA → |
| Colon | glandular cells | High | Protein (IHC) | HPA → |
| Duodenum | glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Soft tissue | chondrocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Low | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | Low | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for KIF5B, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two anti-KIF5B antibodies are listed for Western blotting, both with reported human, mouse, and rat reactivity and WB images. A01934-2 shows an approximately 110 kDa band in six named cell lysates; M01934 shows a HeLa lysate blot. No publication evidence is supplied.
Which to pick: Choose A01934-2 if you want documented WB conditions and examples from human, rat, and mouse cell lysates. Consider M01934 for a HeLa lysate example; its supplied caption gives no band size or protocol details.